Description of Patients With an IPI 0 at Relapse
| Characteristics of the Patients . | No. of Randomized Patients (%) . | |
|---|---|---|
| DHAP . | ABMT . | |
| Histological subtype | ||
| DLCL | 4 (24%) | 7 (35%) |
| IBL | 4 (24%) | 2 (10%) |
| DMCL | 2 (12%) | 7 (35%) |
| FLC | 1 (6%) | 2 (10%) |
| Others | 6 (35%) | 2 (10%) |
| Tumor bulk | ||
| <10 cm | 14 (82%) | 19 (95%) |
| >10 cm | 2 (12%) | 0 (0%) |
| Unknown | 1 (6%) | 1 (5%) |
| Outcome after randomization | ||
| Relapse | 13 (76%) | 12 (60%) |
| BMT after relapse | 7 (41%) | 1 (5%) |
| Characteristics of the Patients . | No. of Randomized Patients (%) . | |
|---|---|---|
| DHAP . | ABMT . | |
| Histological subtype | ||
| DLCL | 4 (24%) | 7 (35%) |
| IBL | 4 (24%) | 2 (10%) |
| DMCL | 2 (12%) | 7 (35%) |
| FLC | 1 (6%) | 2 (10%) |
| Others | 6 (35%) | 2 (10%) |
| Tumor bulk | ||
| <10 cm | 14 (82%) | 19 (95%) |
| >10 cm | 2 (12%) | 0 (0%) |
| Unknown | 1 (6%) | 1 (5%) |
| Outcome after randomization | ||
| Relapse | 13 (76%) | 12 (60%) |
| BMT after relapse | 7 (41%) | 1 (5%) |